These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two support the concept of focusing on ACKR3 as a unique solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar Conditions. As well as the explained https://harrisonn158uww3.wikififfi.com/user